A detailed history of Hb Wealth Management, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Hb Wealth Management, LLC holds 2,208 shares of CRL stock, worth $431,178. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,208
Previous 2,016 9.52%
Holding current value
$431,178
Previous $305,000 13.11%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 23, 2025

BUY
$145.57 - $178.99 $27,949 - $34,366
192 Added 9.52%
2,208 $345,000
Q2 2025

Jul 17, 2025

BUY
$99.75 - $151.89 $201,096 - $306,210
2,016 New
2,016 $305,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.93B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Hb Wealth Management, LLC Portfolio

Follow Hb Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hb Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hb Wealth Management, LLC with notifications on news.